(Q50636235)

17 March 2018

title

Impact of (68)Ga-DOTATATE PET/CT on the surgical management of primary neuroendocrine tumors of the pancreas or ileum. (English)

1 reference

17 March 2018

0 references

9

1 reference

17 March 2018

Peter Bartenstein

7

Peter Bartenstein

1 reference

17 March 2018

Harun Ilhan

1

Harun Ilhan

1 reference

17 March 2018

Franz-Josef Gildehaus

6

Franz-Josef Gildehaus

1 reference

17 March 2018

Christoph J Auernhammer

5

Christoph J Auernhammer

1 reference

17 March 2018

Clemens C Cyran

3

Clemens C Cyran

1 reference

17 March 2018

Wolfgang P Fendler

2

Wolfgang P Fendler

1 reference

17 March 2018

Christine Spitzweg

4

Christine Spitzweg

1 reference

17 March 2018

Martin Angele

8

Martin K Angele

1 reference

17 March 2018

publication date

5 September 2014

1 reference

17 March 2018

Annals of Surgical Oncology

published in

1 reference

17 March 2018

volume

22

1 reference

17 March 2018

issue

1

1 reference

17 March 2018

page(s)

164-171

1 reference

17 March 2018

Peptide receptors as molecular targets for cancer diagnosis and therapy

cites work

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3981-2

ENETS Consensus Guidelines for the management of patients with neuroendocrine neoplasms from the jejuno-ileum and the appendix including goblet cell carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3981-2

NANETS consensus guidelines for the diagnosis of neuroendocrine tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3981-2

The role of 68Ga-DOTATATE PET in patients with neuroendocrine tumors and negative or equivocal findings on 111In-DTPA-octreotide scintigraphy

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3981-2

ENETS Consensus Guidelines for the management of patients with liver and other distant metastases from neuroendocrine neoplasms of foregut, midgut, hindgut, and unknown primary

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3981-2

Somatostatin receptor scintigraphy with [111In-DTPA-D-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3981-2

TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3981-2

TNM staging of midgut and hindgut (neuro) endocrine tumors: a consensus proposal including a grading system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3981-2

Radiolabelling DOTA-peptides with 68Ga

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3981-2

ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms: functional pancreatic endocrine tumor syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3981-2

High management impact of Ga-68 DOTATATE (GaTate) PET/CT for imaging neuroendocrine and other somatostatin expressing tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3981-2

The impact of 68Ga-DOTATOC positron emission tomography/computed tomography on the multimodal management of patients with neuroendocrine tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3981-2

Functional imaging of neuroendocrine tumors with combined PET/CT using 68Ga-DOTATATE (DOTA-DPhe1,Tyr3-octreotate) and 18F-FDG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3981-2

Expression, pharmacology, and functional role of somatostatin receptor subtypes 1 and 2 in human macrophages.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3981-2

Detection of unknown primary neuroendocrine tumours (CUP-NET) using (68)Ga-DOTA-NOC receptor PET/CT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3981-2

Prognostic validity of the American Joint Committee on Cancer staging classification for midgut neuroendocrine tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3981-2

68Ga-DOTA-Tyr3-Octreotide PET in Neuroendocrine Tumors: Comparison with Somatostatin Receptor Scintigraphy and CT

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3981-2

10.1245/S10434-014-3981-2

21 January 2018

Identifiers

DOI

1 reference

17 March 2018

Dimensions Publication ID

1047907540

0 references

1 reference

17 March 2018